ReviewClinical, cosmetic and investigational dermatology2016
Hormonal treatment of acne vulgaris: an update.
Review in Clinical, cosmetic and investigational dermatology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
33 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Alterations in the lipid profile in acne vulgaris patients: A meta-analysis.The Journal of international medical research · 2026Pooled it
- Pooled it
- Efficacy and Safety of Topical Clascoterone Cream, 1%, for Treatment in Patients With Facial Acne: Two Phase 3 Randomized Clinical Trials.JAMA dermatology · 2020Trial
- Overview of the Efficacy and Safety of Topical Hormonal Therapies for the Treatment of Acne Vulgaris: A Narrative Review.The Journal of clinical and aesthetic dermatology · 2026Review
- Pharmacokinetics, Safety, and Skin Irritation and Sensitization Potential of Clascoterone Cream in Early-Phase Clinical Study Participants.Clinical pharmacology in drug development · 2025Article
- The clinical predictors of biochemical hyperandrogenemia and its relation to treatment resistance in women with acne.Postepy dermatologii i alergologii · 2025Article
- Real-World Experience of Clascoterone Cream 1% in Acne Management: Case Series and Canadian Experience.Clinical, cosmetic and investigational dermatology · 2025Article
- Decoding Acne Vulgaris: Insights into Pathogenesis, Treatment Modalities, Diagnosis and Recent Advancements.Recent advances in inflammation & allergy drug discovery · 2025Review
- Dermatological care of gender-diverse patients in Australia.The Australasian journal of dermatology · 2024Review
- Epidemiology and Healthcare of Juvenile and Late-Onset Acne: Claims Data Analysis.Dermatology and therapy · 2024Article
- The role of current synthetic and possible plant and marine phytochemical compounds in the treatment of acne.RSC advances · 2024Review
- Metformin Therapy for Acne Vulgaris: A Meta-Analysis.Pharmaceuticals (Basel, Switzerland) · 2024Review
- Exploring Acne Treatments: From Pathophysiological Mechanisms to Emerging Therapies.International journal of molecular sciences · 2024Review
- Practices, Efficacy, and Reported Side Effects Associated with Isotretinoin Treatment in Palestine.Patient preference and adherence · 2024Article
- Acne vulgaris: A review of the pathophysiology, treatment, and recent nanotechnology based advances.Biochemistry and biophysics reports · 2023Review
- Dermatologic care of patients with differences of sex development.International journal of women's dermatology · 2023Review
- Emerging Insights into the Applicability of Essential Oils in the Management of Acne Vulgaris.Molecules (Basel, Switzerland) · 2023Review
- Insulin Resistance in Patients with Acne Vulgaris.Biomedicines · 2023Article
- Photopneumatic Technology for the Treatment of Mild-to-moderate Acne Vulgaris-A Review and Expert Perspectives.The Journal of clinical and aesthetic dermatology · 2023Article
- Is There a Clinically Relevant Risk of Hyperkalemia with Topical Clascoterone Treatment?The Journal of clinical and aesthetic dermatology · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Acne vulgaris is a common skin condition associated with multiple factors. Although mostly presenting alone, it can likewise present with features of hyperandrogenism and hormonal discrepancies. Of note, hormonal therapies are indicated in severe, resistant-to-treatment cases and in those with monthly flare-ups and when standard therapeutic options are inappropriate. This article serves as an update to hormonal pathogenesis of acne, discusses the basics of endocrinal evaluation for patients with suspected hormonal acne, and provides an overview of the current hormonal treatment options in women.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.